RhIL-11 reverses liver damage in septic mice by STAT3-mediated M-MDSCs induction modulated by a parallel mTORC1 signaling branch

Abstract Background and objective Hyperinflammatory response in early stage of sepsis was the key factor leading to multi-organ injury. Therefore, exploring an effective therapy to attenuate or reverse hyperinflammation was the priority of sepsis treatment. Previous study from our team showed that r...

Full description

Saved in:
Bibliographic Details
Main Authors: Yuefang Liu, Shujun Gao, Zhanghui Li, Lei Yin, Shiyao Ge, Yangjing Zhao, Hui Wang, Bing Wan, Qixiang Shao
Format: Article
Language:English
Published: BMC 2025-06-01
Series:Journal of Inflammation
Subjects:
Online Access:https://doi.org/10.1186/s12950-025-00447-9
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849691521345912832
author Yuefang Liu
Shujun Gao
Zhanghui Li
Lei Yin
Shiyao Ge
Yangjing Zhao
Hui Wang
Bing Wan
Qixiang Shao
author_facet Yuefang Liu
Shujun Gao
Zhanghui Li
Lei Yin
Shiyao Ge
Yangjing Zhao
Hui Wang
Bing Wan
Qixiang Shao
author_sort Yuefang Liu
collection DOAJ
description Abstract Background and objective Hyperinflammatory response in early stage of sepsis was the key factor leading to multi-organ injury. Therefore, exploring an effective therapy to attenuate or reverse hyperinflammation was the priority of sepsis treatment. Previous study from our team showed that recombinant human interleukin-11 (rhIL-11) was a promising anti-inflammation cytokine in sepsis. However, the molecular mechanism was not fully elucidated. This study aims to evaluate the therapeutic potential of rhIL-11 in septic mice model and explore the underlying the molecular mechanism. Methods A cecal ligation and puncture (CLP) model was applied to induce septic mice. Mice were separated into five groups with six animals in each group, including normal, sham, sham + rhIL-11, CLP and CLP + rhIL-11 groups. Therapeutic potential of rhIL-11 was evaluated by comparing body weight, survival time and liver damage (hematoxylin and eosin (H&E) staining, pro-inflammatory cytokines and serum measurements of liver enzymes). Hepatic myeloid-derived suppressor cells (MDSC) percentage was also compared. In vitro, MDSC differentiation from bone marrow (BM) cells was induced in the presence of appropriate stimuli, followed by the proportion and subsets analysis via flow cytometer. The related signal pathways including STAT3 and mTORC1 were detected by western blotting. The effect of MDSCs inhibition by STAT3 and mTORC1 inhibitors on septic mice was evaluated by comparing survival time, liver damage and MDSCs percentage. Results Here, we declared that early treatment of rhIL-11 exerted a liver protective effect and caused the expansion of monocytic myeloid-derived suppressor cells (M-MDSCs) in septic mice model. The results of in vitro studies declared that rhIL-11 promoted differentiation of BM cells into M-MDSCs phenotypically and functionally via activating STAT3 signaling, which was cross-regulated by the mTORC1. Furthermore, we also elucidated that mTORC1 bound directly to STAT3 through an interaction between raptor and TOS motif in STAT3. Finally, inhibition of mTORC1 or STAT3 in vivo blocked the differentiation of M-MDSCs and attenuated liver protective effect of rhIL-11. Conclusions Taken together, these results suggested that early treatment of rhIL-11 in septic mice might reverse the hepatic damage at least in part by inducing the differentiation of M-MDSCs via STAT3 signaling pathway, and STAT3 signaling is modulated by a parallel branch of mTORC1.
format Article
id doaj-art-99a442eb13ef4a189a1d2b73ed8727e9
institution DOAJ
issn 1476-9255
language English
publishDate 2025-06-01
publisher BMC
record_format Article
series Journal of Inflammation
spelling doaj-art-99a442eb13ef4a189a1d2b73ed8727e92025-08-20T03:20:59ZengBMCJournal of Inflammation1476-92552025-06-0122111510.1186/s12950-025-00447-9RhIL-11 reverses liver damage in septic mice by STAT3-mediated M-MDSCs induction modulated by a parallel mTORC1 signaling branchYuefang Liu0Shujun Gao1Zhanghui Li2Lei Yin3Shiyao Ge4Yangjing Zhao5Hui Wang6Bing Wan7Qixiang Shao8Institute of Medical Genetics and Reproductive Immunity, The Digestive and Reproductive System Cancers Precise Prevention Engineering Research Center of Jiangsu Province, Jiangsu College of NursingDepartment of Nuclear Medicine, The Second Affiliated Hospital of Soochow UniversityJiangsu Key Laboratory of Medical Science and Laboratory Medicine, Department of Immunology, School of Medicine, Jiangsu UniversityJiangsu Key Laboratory of Medical Science and Laboratory Medicine, Department of Immunology, School of Medicine, Jiangsu UniversityJiangsu Key Laboratory of Medical Science and Laboratory Medicine, Department of Immunology, School of Medicine, Jiangsu UniversityJiangsu Key Laboratory of Medical Science and Laboratory Medicine, Department of Immunology, School of Medicine, Jiangsu UniversityJiangsu Key Laboratory of Medical Science and Laboratory Medicine, Department of Immunology, School of Medicine, Jiangsu UniversityDepartment of Respiratory and Critical Care Medicine, The Affiliated Jiangning Hospital of Nanjing Medical UniversityInstitute of Medical Genetics and Reproductive Immunity, The Digestive and Reproductive System Cancers Precise Prevention Engineering Research Center of Jiangsu Province, Jiangsu College of NursingAbstract Background and objective Hyperinflammatory response in early stage of sepsis was the key factor leading to multi-organ injury. Therefore, exploring an effective therapy to attenuate or reverse hyperinflammation was the priority of sepsis treatment. Previous study from our team showed that recombinant human interleukin-11 (rhIL-11) was a promising anti-inflammation cytokine in sepsis. However, the molecular mechanism was not fully elucidated. This study aims to evaluate the therapeutic potential of rhIL-11 in septic mice model and explore the underlying the molecular mechanism. Methods A cecal ligation and puncture (CLP) model was applied to induce septic mice. Mice were separated into five groups with six animals in each group, including normal, sham, sham + rhIL-11, CLP and CLP + rhIL-11 groups. Therapeutic potential of rhIL-11 was evaluated by comparing body weight, survival time and liver damage (hematoxylin and eosin (H&E) staining, pro-inflammatory cytokines and serum measurements of liver enzymes). Hepatic myeloid-derived suppressor cells (MDSC) percentage was also compared. In vitro, MDSC differentiation from bone marrow (BM) cells was induced in the presence of appropriate stimuli, followed by the proportion and subsets analysis via flow cytometer. The related signal pathways including STAT3 and mTORC1 were detected by western blotting. The effect of MDSCs inhibition by STAT3 and mTORC1 inhibitors on septic mice was evaluated by comparing survival time, liver damage and MDSCs percentage. Results Here, we declared that early treatment of rhIL-11 exerted a liver protective effect and caused the expansion of monocytic myeloid-derived suppressor cells (M-MDSCs) in septic mice model. The results of in vitro studies declared that rhIL-11 promoted differentiation of BM cells into M-MDSCs phenotypically and functionally via activating STAT3 signaling, which was cross-regulated by the mTORC1. Furthermore, we also elucidated that mTORC1 bound directly to STAT3 through an interaction between raptor and TOS motif in STAT3. Finally, inhibition of mTORC1 or STAT3 in vivo blocked the differentiation of M-MDSCs and attenuated liver protective effect of rhIL-11. Conclusions Taken together, these results suggested that early treatment of rhIL-11 in septic mice might reverse the hepatic damage at least in part by inducing the differentiation of M-MDSCs via STAT3 signaling pathway, and STAT3 signaling is modulated by a parallel branch of mTORC1.https://doi.org/10.1186/s12950-025-00447-9SepsisHepatic damageRecombinant human interleukin-11 (rhIL-11)Monocytic myeloid-derived suppressor cells (M-MDSCs)mTORC1STAT3
spellingShingle Yuefang Liu
Shujun Gao
Zhanghui Li
Lei Yin
Shiyao Ge
Yangjing Zhao
Hui Wang
Bing Wan
Qixiang Shao
RhIL-11 reverses liver damage in septic mice by STAT3-mediated M-MDSCs induction modulated by a parallel mTORC1 signaling branch
Journal of Inflammation
Sepsis
Hepatic damage
Recombinant human interleukin-11 (rhIL-11)
Monocytic myeloid-derived suppressor cells (M-MDSCs)
mTORC1
STAT3
title RhIL-11 reverses liver damage in septic mice by STAT3-mediated M-MDSCs induction modulated by a parallel mTORC1 signaling branch
title_full RhIL-11 reverses liver damage in septic mice by STAT3-mediated M-MDSCs induction modulated by a parallel mTORC1 signaling branch
title_fullStr RhIL-11 reverses liver damage in septic mice by STAT3-mediated M-MDSCs induction modulated by a parallel mTORC1 signaling branch
title_full_unstemmed RhIL-11 reverses liver damage in septic mice by STAT3-mediated M-MDSCs induction modulated by a parallel mTORC1 signaling branch
title_short RhIL-11 reverses liver damage in septic mice by STAT3-mediated M-MDSCs induction modulated by a parallel mTORC1 signaling branch
title_sort rhil 11 reverses liver damage in septic mice by stat3 mediated m mdscs induction modulated by a parallel mtorc1 signaling branch
topic Sepsis
Hepatic damage
Recombinant human interleukin-11 (rhIL-11)
Monocytic myeloid-derived suppressor cells (M-MDSCs)
mTORC1
STAT3
url https://doi.org/10.1186/s12950-025-00447-9
work_keys_str_mv AT yuefangliu rhil11reversesliverdamageinsepticmicebystat3mediatedmmdscsinductionmodulatedbyaparallelmtorc1signalingbranch
AT shujungao rhil11reversesliverdamageinsepticmicebystat3mediatedmmdscsinductionmodulatedbyaparallelmtorc1signalingbranch
AT zhanghuili rhil11reversesliverdamageinsepticmicebystat3mediatedmmdscsinductionmodulatedbyaparallelmtorc1signalingbranch
AT leiyin rhil11reversesliverdamageinsepticmicebystat3mediatedmmdscsinductionmodulatedbyaparallelmtorc1signalingbranch
AT shiyaoge rhil11reversesliverdamageinsepticmicebystat3mediatedmmdscsinductionmodulatedbyaparallelmtorc1signalingbranch
AT yangjingzhao rhil11reversesliverdamageinsepticmicebystat3mediatedmmdscsinductionmodulatedbyaparallelmtorc1signalingbranch
AT huiwang rhil11reversesliverdamageinsepticmicebystat3mediatedmmdscsinductionmodulatedbyaparallelmtorc1signalingbranch
AT bingwan rhil11reversesliverdamageinsepticmicebystat3mediatedmmdscsinductionmodulatedbyaparallelmtorc1signalingbranch
AT qixiangshao rhil11reversesliverdamageinsepticmicebystat3mediatedmmdscsinductionmodulatedbyaparallelmtorc1signalingbranch